MONETA, CLAUDIA
MONETA, CLAUDIA
Dipartimento di Scienze della Salute
Physical activity and systemic treatment outcomes in advanced thyroid cancer.
2025 C. Colombo, D. Ceruti, F. Cervellini, M. Succi, S. De Leo, M. Trevisan, C. Moneta, M. Lugaresi, G. Dionigi, G. Gazzano, L. Persani, L. Fugazzola
Will the autofluorescence take over inadvertent parathyroidectomy?Results from a multicentre cohort study
2025 D. Barbieri, P. Indelicato, S. DE LEO, C. Moneta, S. Coccia, G. Gazzano, L. Giordano, F. LIRA LUCE, D. Canta, L. Fugazzola, M. Bussi, G. Dionigi, M. Trevisan
Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors
2025 M. Muzza, C. Colombo, G. Pogliaghi, E. Carbone, L. Ermellino, M. Succi, C. Moneta, G. Dionigi, D. Gentilini, G. Vannucchi, G. Gazzano, L. Persani, L. Fugazzola
Changing the paradigm: lobectomy for sporadic medullary thyroid cancer
2025 M. Lugaresi, C. Moneta, G. Saruggia, G. Dionigi, G. Gazzano, L. Fugazzola
Impatto della dose iniziale sul trattamento con lenvatinib nel carcinoma tiroideo differenziato avanzato
2025 C. Moneta, M. Trevisan, C. Colombo, M. Succi, M. Lugaresi, D. Ceruti, S. De Leo, L. Fugazzola
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex
2024 C. Colombo, D. Ceruti, M. Succi, S. De Leo, M. Trevisan, C. Moneta, L. Fugazzola
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants
2024 V. Cirello, M. Lugaresi, C. Moneta, P. Dufour, A. Manzo, E. Carbone, C. Colombo, L. Fugazzola, C. Charlier, C. Pirard
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.
2023 S. De Leo, M. Trevisan, C. Moneta, C. Colombo
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer
2023 S. De Leo, M. Trevisan, G.V. Re Sartò, C. Moneta, M. Pirovano, C. Colombo, L. Cosmai, L. Fugazzola
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
2023 S. De Leo, M. Trevisan, C. Colombo, C. Moneta, N. Giancola, L. Fugazzola
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
2022 M. Trevisan, C. Colombo, N. Giancola, C. Moneta, G. Dionigi, L. Fugazzola, S. De Leo
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
2021 C. Colombo, S. De Leo, M. Di Stefano, M. Trevisan, C. Moneta, L. Vicentini, L. Fugazzola